Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China flag China · Delayed Price · Currency is CNY
6.71
-0.02 (-0.30%)
Nov 17, 2026, 3:00 PM CST

SHA:603229 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
951.091,2231,0961,124608.85564.55
Trading Asset Securities
3.773.942.24-4.02110
Cash & Short-Term Investments
954.861,2271,0991,124612.87674.55
Cash Growth
-15.90%11.65%-2.29%83.44%-9.14%-8.73%
Accounts Receivable
257.45146.41196.58132.75134.8166.24
Other Receivables
1.830.921.182.828.491.49
Receivables
259.29147.34197.76135.57143.367.73
Inventory
373.7398.3400.95365.18320.57243.44
Other Current Assets
43.3743.1911.9349.7559.9734.86
Total Current Assets
1,6311,8151,7091,6751,1371,021
Property, Plant & Equipment
1,0221,0371,0411,046950.94601.46
Long-Term Investments
70.672.5672.5667.3750.1432.64
Other Intangible Assets
148.53151.56155.39150.37161.98164.2
Long-Term Deferred Tax Assets
6.733.820.46-6.874.47
Other Long-Term Assets
4.765.353.9912.718.6916.1
Total Assets
2,8843,0852,9822,9522,3151,839

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
215.22270.1351.64410.85519.32402.25
Accrued Expenses
17.5949.3846.8740.1142.9131.63
Short-Term Debt
270.09410.61270.31300.26160.1265.07
Current Portion of Long-Term Debt
23.060.51--9.16-
Current Portion of Leases
-1.281.040.87--
Current Income Taxes Payable
3.76-2.5310.21-5.81
Current Unearned Revenue
0.840.960.917.0612.6323.23
Other Current Liabilities
2.783.181.231.611.282.33
Total Current Liabilities
533.34736.02674.53770.97745.42530.32
Long-Term Debt
21.9944.25--72.7444.86
Long-Term Leases
--1.082.04--
Long-Term Unearned Revenue
40.9135.6234.8934.9123.519.46
Long-Term Deferred Tax Liabilities
---2.0712.51-
Total Liabilities
596.24815.89710.5809.99854.19584.64

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
830.3830.3830.3593.07401.87287.05
Additional Paid-In Capital
440.23440.23440.23677.45394.72509.54
Retained Earnings
1,0691,0501,002871.92665.46459.36
Treasury Stock
-50.01-50.01----
Comprehensive Income & Other
-1.49-1.1-0.83-0.86-0.91-1.14
Shareholders' Equity
2,2882,2692,2722,1421,4611,255
Total Liabilities & Equity
2,8843,0852,9822,9522,3151,839

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
315.14456.65272.43303.17242.02109.93
Net Cash (Debt)
639.73769.86826.1821.06370.85564.62
Net Cash Growth
-15.69%-6.81%0.61%121.40%-34.32%-19.12%
Net Cash Per Share
0.810.941.001.000.460.71
Filing Date Shares Outstanding
825.1825.1828.3830.3787.66787.66
Total Common Shares Outstanding
825.1825.1830.3830.3787.66787.66
Working Capital
1,0981,0791,035903.76391.28490.26
Book Value Per Share
2.772.752.742.581.861.59
Tangible Book Value
2,1402,1182,1161,9911,2991,091
Tangible Book Value Per Share
2.592.572.552.401.651.38
Buildings
-314.84261.11224.84168.11150.71
Machinery
-781.12559.12510.1278.07223.16
Construction In Progress
-285.28495.66526.23685.01379.24